Grace Therapeutics, Inc.
Financial highlights
| Metric | FY 03/31/26 | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | — | — | $0.0 |
| Operating income | -$11.1 | -$16.7 | -$12.9 | -$52.2 | -$15.6 |
| Net income | -$7.8 | -$9.6 | -$12.9 | -$42.4 | -$9.8 |
Shares outstanding 21.0M · Free float 18.9%
Annual filing data through FY ended March 31, 2026; float as of September 10, 2026.